Exforge Deal 'More Pernicious' Than Actavis, Court Told
An alleged deal between Novartis and Par Pharmaceutical to delay a generic of hypertension medication Exforge is illegal because it was far more anticompetitive than what the U.S. Supreme Court dealt with in its landmark Actavis decision, Walgreens and Kroger...To view the full article, register now.
Already a subscriber? Click here to view full article